Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database

PURPOSE: Biologic disease-modifying anti-rheumatic drugs (bDMARDs) are highly effective and safe against juvenile idiopathic arthritis (JIA), which is classified into systemic JIA (sJIA) and the other JIA categories (non-sJIA) according to differences in clinical symptoms and pathophysiology. The pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Takeo, Hirata, Atsushi, Ota, Ryosuke, Hosohata, Keiko, Nishihara, Masami, Neo, Masashi, Katsumata, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422327/
https://www.ncbi.nlm.nih.gov/pubmed/36046102
http://dx.doi.org/10.2147/TCRM.S375890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422327/
https://www.ncbi.nlm.nih.gov/pubmed/36046102
http://dx.doi.org/10.2147/TCRM.S375890

Ejemplares similares